Multimodality Imaging of Neoplastic and Nonneoplastic Solid Lesions of the Pancreas
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Solid lesions of the pancreas represent a heterogeneous group of entities that can be broadly classified as either neoplastic or nonneoplastic. Neoplastic lesions include pancreatic adenocarcinoma, pancreatic neuroendocrine tumor, solid pseudopapillary tumor, pancreatoblastoma, pancreatic lymphoma, metastases to the pancreas, and rare miscellaneous neoplasms. Nonneoplastic lesions include focal pancreatitis, fatty infiltration-replacement, intrapancreatic accessory spleen, congenital anomalies such as prominent pancreatic lobulation and bifid pancreatic tail (pancreatic bifidum), and rare miscellaneous lesions (eg, pancreatic sarcoidosis, Castleman disease of the pancreas). A variety of imaging modalities are available for assessing these solid lesions, including ultrasonography (US), computed tomography (CT), magnetic resonance imaging, endoscopic US, and hybrid nuclear imaging techniques such as single photon emission computed tomography-CT and positron emission tomography-CT, each of which has its own strengths and limitations. Accurate diagnosis can be challenging, and use of a multimodality imaging approach is often helpful in equivocal or complex cases. Knowledge of relevant clinical information and key radiologic features is essential for confident lesion characterization and differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imaging and localization of islet-cell tumours of the pancreas on CT and MRI.
Noone, T. C., Hosey, J., Firat, Z., & Semelka, R. C. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.013 · Cited by 217
Winter, J. M., Cameron, J. L., Lillemoe, K. D., Campbell, K. A., Chang, D., Riall, T. S., Coleman, J., Sauter, P. K., Canto, M., Hruban, R. H., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000216763.27673.97 · Cited by 156 · cited 2×
“The serum a-fetoprotein level is elevated in 25%–33% of cases (1).”
Background
Cited by
Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and Management
Sahani, D. V., Bonaffini, P. A., Fernández–Del Castillo, C., & Blake, M. A. (2013) · Radiology · doi:10.1148/radiol.12112512 · Cited by 191
Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
Elbanna, K. Y., Jang, H.-J., & Kim, T. K. (2020) · Insights into Imaging · doi:10.1186/s13244-020-00861-y · Cited by 162
“Metastases from renal cell and hepatocellular carcinomas are typically hypervascular and readily differentiated from the hypovascular PDAC; however, metastatic masses may attain larger size and develop central necrosis [99].”
BackgroundInfluentialFactors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma
Kang, J. D., Clarke, S. E., & Costa, A. F. (2021) · European Radiology · doi:10.1007/s00330-020-07307-5 · Cited by 84
Imaging Evaluation of Pancreatic Cancer
Feldman, M. K., & Gandhi, N. S. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.07.007 · Cited by 41
Metadata
- Authors
- Low, G., Panu, A., Millo, N., & Leen, E.
- Venue
- RadioGraphics
- Published
- 2011-07
- Volume
- 31
- Issue
- 4
- Pages
- 993-1015
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2138022371
- Cited by
- 240
- References
- 2
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.